{"id":7796,"date":"2021-12-16T10:33:32","date_gmt":"2021-12-16T15:33:32","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/%ce%bf%ce%be%ce%b5%ce%b9%ce%ba%ce%ae-%ce%b1%ce%b3%ce%b3%ce%b5%ce%b9%ce%bf%cf%84%ce%b5%ce%bd%cf%83%ce%af%ce%bd%ce%b7-val5-angiotensin-ii-cas-58-49-1\/"},"modified":"2021-12-16T10:33:32","modified_gmt":"2021-12-16T15:33:32","slug":"%ce%bf%ce%be%ce%b5%ce%b9%ce%ba%ce%ae-%ce%b1%ce%b3%ce%b3%ce%b5%ce%b9%ce%bf%cf%84%ce%b5%ce%bd%cf%83%ce%af%ce%bd%ce%b7-val5-angiotensin-ii-cas-58-49-1","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/el\/product\/%ce%bf%ce%be%ce%b5%ce%b9%ce%ba%ce%ae-%ce%b1%ce%b3%ce%b3%ce%b5%ce%b9%ce%bf%cf%84%ce%b5%ce%bd%cf%83%ce%af%ce%bd%ce%b7-val5-angiotensin-ii-cas-58-49-1\/","title":{"rendered":"\u039f\u03be\u03b5\u03b9\u03ba\u03ae \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\/ (Val5)-Angiotensin II CAS 58-49-1"},"content":{"rendered":"<h2><strong>\u039f\u03be\u03b5\u03b9\u03ba\u03ae \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\/ (Val5)-Angiotensin II CAS 58-49-1<\/strong><\/h2>\n<p>\u038c\u03bd\u03bf\u03bc\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03bf\u03c2: \u039f\u03be\u03b5\u03b9\u03ba\u03ae \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7<br \/>\n\u03a3\u03c5\u03bd\u03ce\u03bd\u03c5\u03bc\u03b1: [VAL5]-ANGIOTENSIN II;[VAL5] ANGIOTENSIN II HUMAN;ASP-ARG-VAL-TYR-VAL-HIS-PRO-PHE;DRVYVHPF;5-L-Valine \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II);\u0391\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II 5-\u03b2\u03b1\u03bb\u03af\u03bd\u03b7 (\u03b2\u03b1\u03bb\u03af\u03bd\u03b7 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II; \u03b2\u03b1\u03bb\u03af\u03bd\u03b7 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II; VALINE ANGIOTENSIN II;5-L-VALINE ANGIOTENSIN II<br \/>\nCAS: 58-49-1<br \/>\nMF: C49H69N13O12<br \/>\nMW: 1032.17<br \/>\nEINECS:<br \/>\n\u039a\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03af\u03b5\u03c2 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03c9\u03bd:<br \/>\nMol \u0391\u03c1\u03c7\u03b5\u03af\u03bf: 58-49-1.mol<\/p>\n<p>\u0397 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b1\u03c3\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03b5\u03af\u03b4\u03bf\u03c2 \u03c0\u03b5\u03c0\u03c4\u03b9\u03b4\u03b9\u03ba\u03ae\u03c2 \u03bf\u03c5\u03c3\u03af\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03ad\u03c7\u03b5\u03b9 \u03b9\u03c3\u03c7\u03c5\u03c1\u03cc \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c3\u03c5\u03c3\u03c4\u03b1\u03bb\u03c4\u03b9\u03ba\u03cc \u03ba\u03b1\u03b9 \u03b4\u03b9\u03b5\u03b3\u03b5\u03af\u03c1\u03b5\u03b9 \u03c4\u03b7\u03bd \u03ad\u03ba\u03ba\u03c1\u03b9\u03c3\u03b7 \u03b1\u03bb\u03b4\u03bf\u03c3\u03c4\u03b5\u03c1\u03cc\u03bd\u03b7\u03c2 \u03b1\u03c0\u03cc \u03bf \u03c6\u03bb\u03bf\u03b9\u03cc\u03c2 \u03c4\u03c9\u03bd \u03b5\u03c0\u03b9\u03bd\u03b5\u03c6\u03c1\u03b9\u03b4\u03af\u03c9\u03bd \u03a3\u03c5\u03bc\u03bc\u03b5\u03c4\u03ad\u03c7\u03b5\u03b9 \u03c3\u03c4\u03b7 \u03c1\u03cd\u03b8\u03bc\u03b9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c1\u03c4\u03b7\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03c0\u03af\u03b5\u03c3\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03c9\u03bd \u03c3\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ce\u03bd \u03c5\u03b3\u03c1\u03ce\u03bd. \u039c\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c7\u03c9\u03c1\u03b9\u03c3\u03c4\u03b5\u03af \u03c3\u03b5 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 I-VII \u03ba\u03b1\u03b9 \u03c5\u03c0\u03ac\u03c1\u03c7\u03bf\u03c5\u03bd \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 \u0399, \u03c4\u03b7\u03bd \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 III.<\/p>\n<p>&lt; &amp;&gt; <strong>\u039f\u03be\u03b5\u03b9\u03ba\u03ae \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\/ (Val5)-\u0391\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II CAS 58-49-1 \u03a7\u03b7\u03bc\u03b9\u03ba\u03ad\u03c2 \u03b9\u03b4\u03b9\u03cc\u03c4\u03b7\u03c4\u03b5\u03c2<\/strong><br \/>\n\u03b8\u03b5\u03c1\u03bc\u03bf\u03ba\u03c1\u03b1\u03c3\u03af\u03b1 \u03b1\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7\u03c2 -20\u00b0C<br \/>\n\u03c0\u03c5\u03ba\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 1,45\u00b10,1 g\/cm3(\u03a0\u03c1\u03bf\u03b2\u03bb\u03b5\u03c0\u03cc\u03bc\u03b5\u03bd\u03b7)<br \/>\n\u03bc\u03bf\u03c1\u03c6\u03ae \u03c3\u03ba\u03cc\u03bd\u03b7\u03c2<br \/>\n pKa 3,56\u00b10,10 (\u03a0\u03c1\u03bf\u03b2\u03bb\u03b5\u03c0\u03cc\u03bc\u03b5\u03bd\u03bf)<br \/>\nInChIKey JVCJXRGXGITABA-IAQGTVMASA-N<br \/>\nCAS \u0391\u03bd\u03b1\u03c6\u03bf\u03c1\u03ac \u03b2\u03ac\u03c3\u03b7\u03c2 \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd <strong>58-49-1<\/strong> <\/p>\n<p> \u0395\u03c6\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae <strong>ication&amp;Function of Angiotensin Acetate\/ (Val5)-Angiotensin II CAS 58-49-1<\/strong><br \/>\nAcetate angiotensin, \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b3\u03bd\u03c9\u03c3\u03c4\u03ae \u03c9\u03c2 (Val5)-Angiotensin II, \u03b5\u03af\u03bd\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03b1\u03bd\u03ac\u03bb\u03bf\u03b3\u03bf \u03c4\u03b7\u03c2 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\u03c2 II \u03c0\u03bf\u03c5 \u03b5\u03af\u03bd\u03b1\u03b9 \u03b1\u03b3\u03c9\u03bd\u03b9\u03c3\u03c4\u03ae\u03c2 \u03c4\u03c9\u03bd \u03c5\u03c0\u03bf\u03b4\u03bf\u03c7\u03ad\u03c9\u03bd \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\u03c2 AT1. \u0397 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 \u03b5\u03af\u03bd\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03bf\u03bb\u03b9\u03b3\u03bf\u03c0\u03b5\u03c0\u03c4\u03af\u03b4\u03b9\u03bf \u03ba\u03b1\u03b9 \u03b5\u03af\u03bd\u03b1\u03b9 \u03bc\u03b9\u03b1 \u03bf\u03c1\u03bc\u03cc\u03bd\u03b7 \u03ba\u03b1\u03b9 \u03ad\u03bd\u03b1 \u03b9\u03c3\u03c7\u03c5\u03c1\u03cc \u03b4\u03b9\u03c8\u03bf\u03b3\u03cc\u03bd\u03bf. \u03a0\u03c1\u03bf\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03bf \u03c0\u03c1\u03cc\u03b4\u03c1\u03bf\u03bc\u03bf \u03bc\u03cc\u03c1\u03b9\u03bf \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03b9\u03bd\u03bf\u03b3\u03cc\u03bd\u03bf, \u03bc\u03b9\u03b1 \u03c3\u03c6\u03b1\u03b9\u03c1\u03af\u03bd\u03b7 \u03bf\u03c1\u03bf\u03cd \u03c0\u03bf\u03c5 \u03c0\u03b1\u03c1\u03ac\u03b3\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03bf \u03ae\u03c0\u03b1\u03c1. \u03a0\u03b1\u03af\u03b6\u03b5\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03cc \u03c1\u03cc\u03bb\u03bf \u03c3\u03c4\u03bf \u03c3\u03cd\u03c3\u03c4\u03b7\u03bc\u03b1 \u03c1\u03b5\u03bd\u03af\u03bd\u03b7\u03c2-\u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\u03c2.<\/p>\n<p>\u0397 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b1\u03c3\u03af\u03bd\u03b7 II \u03b5\u03af\u03bd\u03b1\u03b9 \u03ad\u03bd\u03b1\u03c2 \u03b9\u03c3\u03c7\u03c5\u03c1\u03cc\u03c2 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c3\u03c5\u03c3\u03c4\u03b1\u03bb\u03c4\u03b9\u03ba\u03cc\u03c2 \u03c0\u03b1\u03c1\u03ac\u03b3\u03bf\u03bd\u03c4\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03b4\u03b7\u03bc\u03b9\u03bf\u03c5\u03c1\u03b3\u03b5\u03af\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7 \u03b4\u03b9\u03b1\u03b4\u03bf\u03c7\u03b9\u03ba\u03ae \u03b4\u03c1\u03ac\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03c1\u03b5\u03bd\u03af\u03bd\u03b7\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03bf\u03c5 \u03bc\u03b5\u03c4\u03b1\u03c4\u03c1\u03b5\u03c0\u03c4\u03b9\u03ba\u03bf\u03cd \u03b5\u03bd\u03b6\u03cd\u03bc\u03bf\u03c5 \u03c4\u03b7\u03c2 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\u03c2 \u03c3\u03c4\u03bf \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03b9\u03bd\u03bf\u03b3\u03cc\u03bd\u03bf. \u039f\u03b9 \u03b2\u03b9\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ad\u03c2 \u03b4\u03c1\u03b1\u03c3\u03c4\u03b7\u03c1\u03b9\u03cc\u03c4\u03b7\u03c4\u03b5\u03c2 \u03c4\u03b7\u03c2 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7\u03c2 \u0399\u0399 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c4\u03b7 \u03c1\u03cd\u03b8\u03bc\u03b9\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c1\u03c4\u03b7\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03c0\u03af\u03b5\u03c3\u03b7\u03c2, \u03c4\u03b7\u03bd \u03b9\u03c3\u03bf\u03c1\u03c1\u03bf\u03c0\u03af\u03b1 \u03b1\u03bb\u03b1\u03c4\u03b9\u03bf\u03cd \u03ba\u03b1\u03b9 \u03bd\u03b5\u03c1\u03bf\u03cd \u03ba\u03b1\u03b9 \u03c4\u03bf\u03bd \u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03cc \u03c4\u03cc\u03bd\u03bf. \u0395\u03c0\u03b9\u03c0\u03bb\u03ad\u03bf\u03bd, \u03b7 \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7 II \u03b4\u03b9\u03b5\u03b3\u03b5\u03af\u03c1\u03b5\u03b9 \u03b4\u03b9\u03ac\u03c6\u03bf\u03c1\u03b1 \u03ad\u03bd\u03b6\u03c5\u03bc\u03b1 \u03cc\u03c0\u03c9\u03c2 \u03b7 \u03bf\u03be\u03b5\u03b9\u03b4\u03ac\u03c3\u03b7 NADPH.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u038c\u03bd\u03bf\u03bc\u03b1 \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03bf\u03c2: \u039f\u03be\u03b5\u03b9\u03ba\u03ae \u03b1\u03b3\u03b3\u03b5\u03b9\u03bf\u03c4\u03b5\u03bd\u03c3\u03af\u03bd\u03b7<br \/>\nCAS: 58-49-1<br \/>\nMF: C49H69N13O12<br \/>\nMW: 1032.17<br \/>\nMol \u0391\u03c1\u03c7\u03b5\u03af\u03bf: 58-49-1.mol<\/p>\n","protected":false},"featured_media":2292,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1967],"class_list":{"0":"post-7796","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-angiotensin-acetate-val5-angiotensin-ii-cas-58-49-1-el","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/product\/7796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/comments?post=7796"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/media\/2292"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/media?parent=7796"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/product_brand?post=7796"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/product_cat?post=7796"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/el\/wp-json\/wp\/v2\/product_tag?post=7796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}